ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
Ali E. Dabiri, William K. Hagan, Donald A. Swenson, Kenneth A. Krohn
Nuclear Technology | Volume 92 | Number 1 | October 1990 | Pages 127-133
Technical Paper | Development of Nuclear Gas Cleaning and Filtering Techniques / Radioisotopes and Isotope Separation | doi.org/10.13182/NT90-A34492
Articles are hosted by Taylor and Francis Online.
The feasibility of using a radio-frequency quadrupole (RFQ) accelerator to accelerate 3He++for use in positron emission tomography (PET) is shown. The 3He++ RFQ is extremely lightweight in comparison to a cyclotron, but can nevertheless produce all four radioisotopes of interest (18F, 13N, 15O, and 11C) in more than adequate quantities. Due to the neutron-poor nature of 3He++, the desired positron emitters can be produced from naturally abundant target isotopes. In addition, target reactions and collisions with the accelerating structure produce relatively small numbers of neutrons compared to proton and deuteron systems. This yields two economic advantages. Enriched 13C, 15N, and 18O target materials are not required. Also, the shielding requirements are reduced considerably, and there is no need for radiation shielding around the accelerator. This reduced shielding results in a factor of 8 reduction in total facility shielding weight compared to a proton/deuteron cyclotron facility. The order of magnitude reduction in facility weight, the virtual elimination of the accelerator weight, and the relative lack of residual induced activity gives rise to the possibility of a radiopharmaceutical production system that is less expensive than present systems and may ultimately be transportable. Such a system could make PET imaging technology far more accessible geographically and financially than it is at present.